Inventor
BISWAS KAUSTAV
US16 patents
⚠️ This page may combine multiple inventors who share the name “BISWAS KAUSTAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
13 patentsUS9096527B2Aug 4, 2015
TRPM8 antagonists and their use in treatments
AMGEN INC5 citations72
US7635715B2Dec 22, 2009
Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AMGEN INC7 citations71
US7425631B2Sep 16, 2008
Compounds and methods of use
AMGEN INC2 citations62
US8048892B2Nov 1, 2011
Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AMGEN INC2 citations60
US7728130B2Jun 1, 2010
Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity
AMGEN INC2 citations60
US7393852B2Jul 1, 2008
Piperazine derivatives and methods of use
AMGEN INC3 citations60
US8012968B2Sep 6, 2011
Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
AMGEN INC4 citations59
US7662811B2Feb 16, 2010
1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
AMGEN INC1 citations51
US7928139B2Apr 19, 2011
Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AMGEN INC0 citations50
US8759532B2Jun 24, 2014
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
AMGEN INC0 citations49
US8017626B2Sep 13, 2011
Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
AMGEN INC1 citations48
US8952009B2Feb 10, 2015
Chroman derivatives as TRPM8 inhibitors
AMGEN INC0 citations41
US10344060B2Jul 9, 2019
Potent and selective inhibitors of Nav1.7
AMGEN INC0 citations38